Literature DB >> 12408728

Spectral and crystallographic study of pyridinic analogues of nimesulide: determination of the active form of methanesulfonamides as COX-2 selective inhibitors.

Fabien Julémont1, Xavier de Leval, Catherine Michaux, Jacques Damas, Caroline Charlier, François Durant, Bernard Pirotte, Jean-Michel Dogné.   

Abstract

Compound 7, N-(3-phenoxy-4-pyridinyl)trifluoromethanesulfonamide, showed in vitro (whole blood assay) a strong inhibitory activity on the two cyclooxygenase (COX) enzymes (IC(50)(COX-1) = 2.2 microM and IC(50)(COX-2) = 0.4 microM), being more active but less COX-2-selective than nimesulide. Physicochemical studies and structural analyses indicated that the anionic sulfonamidate species seemed to be the active form of methanesulfonamides, which optimally interacted with the COX enzymes' active sites.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408728     DOI: 10.1021/jm020920n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Time-dependent diaryl ether inhibitors of InhA: structure-activity relationship studies of enzyme inhibition, antibacterial activity, and in vivo efficacy.

Authors:  Pan Pan; Susan E Knudson; Gopal R Bommineni; Huei-Jiun Li; Cheng-Tsung Lai; Nina Liu; Miguel Garcia-Diaz; Carlos Simmerling; Sachindra S Patil; Richard A Slayden; Peter J Tonge
Journal:  ChemMedChem       Date:  2014-03-11       Impact factor: 3.466

2.  From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation.

Authors:  Bo Zhong; Xiaohan Cai; Snigdha Chennamaneni; Xin Yi; Lili Liu; John J Pink; Afshin Dowlati; Yan Xu; Aimin Zhou; Bin Su
Journal:  Eur J Med Chem       Date:  2011-11-15       Impact factor: 6.514

3.  Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors.

Authors:  Carlos J A Ribeiro; Jayakanth Kankanala; Jiashu Xie; Jessica Williams; Hideki Aihara; Zhengqiang Wang
Journal:  Bioorg Med Chem Lett       Date:  2018-11-22       Impact factor: 2.823

4.  Synthesis and biological evaluation of novel sulfonanilide compounds as antiproliferative agents for breast cancer.

Authors:  Bin Su; Michael V Darby; Robert W Brueggemeier
Journal:  J Comb Chem       Date:  2008-04-02

5.  Selective regulation of aromatase expression for drug discovery.

Authors:  Robert W Brueggemeier; Bin Su; Michael V Darby; Yasuro Sugimoto
Journal:  J Steroid Biochem Mol Biol       Date:  2009-12-01       Impact factor: 4.292

6.  Aromatase and COX in breast cancer: enzyme inhibitors and beyond.

Authors:  Robert W Brueggemeier; Bin Su; Yasuro Sugimoto; Edgar S Díaz-Cruz; Danyetta D Davis
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-25       Impact factor: 4.292

Review 7.  CoMFA/CoMSIA/HQSAR and Docking Study of the Binding Mode of Selective Cyclooxygenase (COX-2) Inhibitors.

Authors:  Haifeng Chen; Qiang Li; Xiaojun Yao; BoTao Fan; Shengang Yuan; A Panaye; J P Doucet
Journal:  QSAR Comb Sci       Date:  2004-02-18

8.  Synthesis and pharmacological evaluation of novel phenyl sulfonamide derivatives designed as modulators of pulmonary inflammatory response.

Authors:  Maria Letícia de Castro Barbosa; Thiago José Figueira Ramos; Ana Carolina Santos de Arantes; Marco Aurélio Martins; Patrícia Machado Rodrigues E Silva; Eliezer J Barreiro; Lídia Moreira Lima
Journal:  Molecules       Date:  2012-12-10       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.